Cardiovascular risk and physical activity practice in children and adolescents of Muzambinho/MG: influence of gender and age

INTRODUÇÃO E OBJETIVO: A doença cardiovascular inicia na infância e está atrelada à presença de fatores de risco cardiovascular (FRC). A prevalência desses fatores varia em diferentes populações brasileiras, tendo sido estudada principalmente em cidades de médio e grande porte. Este estudo avaliou a prevalência dos FRC e da prática de atividade física (AF) em crianças e adolescentes de Muzambinho, uma cidade de pequeno porte. MÉTODO: Foram avaliados 205 sujeitos (entre sete e 18 anos - 108 do gênero masculino). Foram medidos: peso, estatura, glicemia, colesterolemia, pressão arterial (PA) e prática de AF. As comparações foram realizadas pelo teste do Qui-quadrado. RESULTADOS: A prevalência de sobrepeso foi de 19% e de valores alterados de PA, glicemia e colesterolemia foram de, respectivamente, 11, 5 e 15%. Não houve diferença na prevalência dos FRC entre os sexos. O tabagismo, o alcoolismo, a PA alterada e a insuficiência de AF aumentaram com a idade. Setenta e nove por cento dos sujeitos praticavam AF de locomoção, 10% ocupacional, 97% nas aulas de educação física, 72% no recreio e 90% de lazer. Noventa e dois por cento foram considerados ativos. A prática de AF ocupacional foi maior nas meninas e aumentou nos meninos com a idade. A prevalência de AF de lazer e recreio diminuiu com a idade nos dois sexos. CONCLUSÃO: A prevalência de FRC, exceto do sedentarismo, foi expressiva, não diferiu entre os sexos e aumentou com a idade. A prática de AF de todos os tipos foi alta, diferenciou-se entre os sexos e diminuiu com a idade.INTRODUCTION AND OBJECTIVE: Cardiovascular disease begins at infancy and it has been linked to the presence of cardiovascular risk factors (CRF). Prevalence of these factors varies a lot among different Brazilian populations and has been mostly studied in big and medium size cities. Thus, this study assessed the prevalence of CRF and physical activity (PA) in children and adolescents from Muzambinho, a small city in the state of Minas Gerais. METHODS: 205 subjects (7 to 18 years - 108 males) were studied. Body weight and height, glycemia, cholesterolemia, blood pressure (BP), and PA were measured. Comparisons were made by Qui-square test. RESULTS: Obesity and altered values of BP, glycemia, and cholesterolemia were found, respectively, in 19, 11, 5 and 15% of the subjects. There was no difference between genders, while the prevalence of smokers, drinkers, altered BP, and inactivity increased with age. Seventy-nine percent of the subjects practiced community PA; 10% occupational PA; 97% physical education classes; 72% PA during school recess; and 90% leisure time PA. Ninety-two percent of them were active. Occupational PA was higher in girls, and increased with age in boys. Leisure time and during school recess PA decreased with age in both genders. CONCLUSION: Except for physical inactivity, prevalence of CRF was high, did not differ between genders, and increased with age. High levels of all kinds of PA were found; they differed between genders, and decreased with age.CNPqUSP - Pró-Reitoria de Graduaçã

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation : Data From ROCKET AF

M. Kaste on työryhmän ROCKET AF Steering Comm jäsen.Background-Atrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all-cause mortality may guide interventions. Methods and Results-In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) study, patients with nonvalvular atrial fibrillation were randomized to rivaroxaban or dose-adjusted warfarin. Cox proportional hazards regression with backward elimination identified factors at randomization that were independently associated with all-cause mortality in the 14 171 participants in the intention-to-treat population. The median age was 73 years, and the mean CHADS(2) score was 3.5. Over 1.9 years of median follow-up, 1214 (8.6%) patients died. Kaplan-Meier mortality rates were 4.2% at 1 year and 8.9% at 2 years. The majority of classified deaths (1081) were cardiovascular (72%), whereas only 6% were nonhemorrhagic stroke or systemic embolism. No significant difference in all-cause mortality was observed between the rivaroxaban and warfarin arms (P=0.15). Heart failure (hazard ratio 1.51, 95% CI 1.33-1.70, P= 75 years (hazard ratio 1.69, 95% CI 1.51-1.90, P Conclusions-In a large population of patients anticoagulated for nonvalvular atrial fibrillation, approximate to 7 in 10 deaths were cardiovascular, whereasPeer reviewe

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)